DRAWINGS BY SAGAR

The IBD Unit concentrates its research activities on aspects of pathophysiology, diagnosis and treatment of IBD. Specifically, our focus is upon discovering mechanisms bearing direct therapeutic implications. Thus, projects are directed towards the characterization of differential patterns of immune response in early and late CD, which may lead to personalized treatment options based on immune characteristics, and on the identification of molecular factors that maintain remission in these inflammatory disorders. In the area of diagnostics the group is heading initiatives on the use of magnetic resonance imaging for the evaluation of inflammatory lesions in the intestine. In the area of therapeutics the main focus of the group is the development of innovative forms of cell therapies for human IBD, including the use of hematopoietic stem cells, tolerogenic dendritic cells, and epithelial stem cells... Our research group possesses the know-how for characterizing the mechanistic aspects..

Also known as: ibd-bcn

Primary location: Barcelona Spain